Bacteria News and Research

RSS

Novel bone implants can keep germs at bay

Hospital germs can be fatal, since they are resistant to antibiotics. As a result, alternative methods of defense against bacteria are in demand. Fortunately, a German-French research team has been able to develop bone implants that keep the germs at bay.

11 Jun 2014

Dendrimer offers a simple way of creating vesicles

One of the defining features of cells is their membranes. Each cell's repository of DNA and protein-making machinery must be kept stable and secure from invaders and toxins. Scientists have attempted to replicate these properties, but, despite decades of research, even the most basic membrane structures, known as vesicles, still face many problems when made in the lab. They are difficult to make at consistent sizes and lack the stability of their biological counterparts.

11 Jun 2014

New device designed to detect foodborne bacteria

A new device designed to sample and detect foodborne bacteria is being trialled by scientists at the University of Southampton.

11 Jun 2014

Antimicrobial abrasion-resistant coatings with long-term effect for killing germs reliably

Researchers at the INM - Leibniz Institute for New Materials have now produced antimicrobial abrasion-resistant coatings with both silver and copper colloids with a long-term effect that kill germs reliably and at the same time prevent germs becoming established.

11 Jun 2014

Researchers solve structure of key protein that drives DNA copying in plasmids

Staph infections that become resistant to multiple antibiotics don't happen because the bacteria themselves adapt to the drugs, but because of a kind of genetic parasite they carry called a plasmid that helps its host survive the antibiotics.

10 Jun 2014

S. pneumoniae is major cause of severe pneumonia in Gambian children

Researchers have published a detailed survey of children with pneumonia in the Gambia, which reveals that Streptococcus pneumoniae is the predominant aetiological agent and that multiple pathogens are present in at least half of cases.

9 Jun 2014

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

When it comes to the emergence of antimalarial drug resistance, it's not a question of 'if' but 'when'. In order to keep up with the quickly evolving Plasmodium parasite - the cause of malaria - new ways to treat and control the disease must be found.

9 Jun 2014

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

Stunning scientific images of blood, brain, bacteria, viruses and more, enlarged by as much as 50,000 times, are on display in an exhibit called "Life: Magnified," on view through November 2014 at Washington Dulles International Airport's Gateway Gallery.

9 Jun 2014

New methods for detection of fecal pollution in Norwegian watercourses

The Norwegian Institute for Agricultural and Environmental Research, Bioforsk, has tested and implemented a set of methods for the detection of fecal pollution in Norwegian watercourses.

9 Jun 2014

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).

9 Jun 2014

Infants exposed to bacterial species in house dust are less likely to develop asthma

Infants exposed to a diverse range of bacterial species in house dust during the first year of life appear to be less likely to develop asthma in early childhood, according to a new study published online on June 6, 2014, in the Journal of Allergy and Clinical Immunology.

9 Jun 2014

Bacteria exposure may help protect babies from wheezing and allergic disease

Research funded by the National Institutes of Health suggests that exposure to specific combinations of allergens and bacteria within the first year of life may protect children from wheezing and allergic disease.

9 Jun 2014

Scientists design nanoparticle to target tumor cells

Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.

9 Jun 2014

Progress in constructing protein nanomachines

A route for constructing protein nanomachines engineered for specific applications may be closer to reality.

6 Jun 2014

Research finding could lead to new strategies for malaria control

Researchers have found the first evidence of an intercellular bacterial infection in natural populations of two species of Anopheles mosquitoes, the major vectors of malaria in Africa. The infection, called Wolbachia, has been shown in labs to reduce the incidence of pathogen infections in mosquitoes and has the potential to be used in controlling malaria-transmitting mosquito populations.

6 Jun 2014

Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Whether through the use of alcohol-containing caps or basic cleaning of the injection port of the central line, infection preventionists at three hospitals are finding successful ways to stop germs from entering central line catheters and causing bloodstream infections in patients.

6 Jun 2014

Newborns exposed to rodent, pet dander and household bacteria less likely to have allergy, asthma

Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children's Center and other institutions.

6 Jun 2014

Urinary microbiota implicated in overactive bladder

Contrary to popular belief, urine is not sterile and contains a range of microbiological organisms that vary in health and disease, US scientists have shown.

5 Jun 2014

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

5 Jun 2014

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

5 Jun 2014

Bacteria News and Research

Novel bone implants can keep germs at bay

Dendrimer offers a simple way of creating vesicles

New device designed to detect foodborne bacteria

Antimicrobial abrasion-resistant coatings with long-term effect for killing germs reliably

Researchers solve structure of key protein that drives DNA copying in plasmids

S. pneumoniae is major cause of severe pneumonia in Gambian children

Protein-kinase interactions offer a new way to fight antimalarial drug resistance

Scientific images of blood, brain, bacteria are on display at Washington Dulles International Airport

New methods for detection of fecal pollution in Norwegian watercourses

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Infants exposed to bacterial species in house dust are less likely to develop asthma

Bacteria exposure may help protect babies from wheezing and allergic disease

Scientists design nanoparticle to target tumor cells

Progress in constructing protein nanomachines

Research finding could lead to new strategies for malaria control

Disinfection caps, 'scrub-the-hub' regimens reduce bloodstream infections, cut costs

Newborns exposed to rodent, pet dander and household bacteria less likely to have allergy, asthma

Urinary microbiota implicated in overactive bladder

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo